Konferencja Naukowa 2023
Programme of the International Conference CLINICAL GENETICS OF CANCER (download)
We would like to thank all participants for taking part in the International Conference „Clinical Genetics of Cancer 2023”.
We invite you to participate in the Scientific Conference next year.
ABSTRAKTY
Abstrakt 1. Scott Rodney – Are there germline genetic variants that correlate with mutational events in adult brain tumours?
Abstrakt 2. Hemminki Kari – Germline genetics of familial cancer
Abstrakt 3. Försti Asta – Germline variants in cancer patients with personal and family history of colorectal cancer
Abstrakt 4. Bisseling Tanya – Hereditary diffuse type gastric cancer: CDH1 – An update and a glimpse of preliminary science
Abstrakt 5. Nowakowska Dorota – HDGC (Hereditary Diffuse Gastric Cancer) – challenges of care- preliminary Polish results
Abstrakt 6. Irmejs Arvids – Early Insights from Hereditary Breast and Ovarian Cancer Risk Genetic Screening Pilot in Latvia
Abstrakt 7. Elsakov Pavel – Mirror results in population screening of Breast and Colorectal cancer in Lithuania.
Abstrakt 8. Vodicka Pavel – Genomic instability, microenvironment and telomere homeostasis in solid malignancies
Abstrakt 9. Pławski Andrzej – c.268G>A substitution in NTHL1 gene in Polish polyposis patients
Abstrakt 10. Baszuk Piotr – Blood copper and arsenic levels and the occurrence of colorectal cancer
Abstrakt 11. Grzybowska Ewa – Genetic polymorphisms, response to treatment and adverse effects in breast cancer patients treated with FAC chemotherapy
Abstrakt 12. Bińkowski Jan – Different histological types of breast cancer share common epigenetic and transcriptomic signature that predicts clinical outcome
Abstrakt 13. Wojdacz Tomasz – Detection of constitutional epimutation of BRCA1is only possible with highly sensitive method
Abstrakt 14. Taryma-Leśniak Olga – Genomes of BRCA1 mutation and epimutation carriers appear to acquire specific epigenetic signature
Abstrakt 15. Przybyłowicz Patrycja – Epigenetic age of female BRCA1 mutation carriers appears not to be correlated with their chronological age
Abstrakt 16. Siwiec Ewa – DMSA in lowering blood Pb cancerogenic level
Abstrakt 17. Szwiec Marek – Ratio of blood Zn/Cu levels as a marker of survival in breast cancer patients
Abstrakt 18. Pietrzak Sandra – Serum Essential Elements and Survival after Cancer Diagnosis
Abstrakt 19. Matuszczak Milena – Correlation between Se, Zn levels and survival among prostate cancer patients
Abstrakt 20. Cybulski Cezary – Mutations in the ATRIP gene predispose to breast cancer
Abstrakt 21. Mądry Radosław – The place of genetic testing in the treatment of endometrial cancer – consequence of the TCGA Molecular Classification and the new drugs
Abstrakt 22. Mądry Radosław – Simultaneous risk reduction surgery – mastectomy and adnexectomy – a new treatment option for BRCA mutation carriers – a win-win strategy for everyone
Abstrakt 23. Heise Marta – Clinical significance of germline variants in ASXL1, CHD1, IDH1, SETD2 and TET2 epigenetic genes and their association with prostate cancer risk in Polish men – preliminary results
Abstrakt 24. Bąk Aneta – Germline mutations associated with acute myeloid leukemia
Abstrakt 25. Kałużewski Bogdan – Propozycja zmiany osi czasu w aplikacji badań genetycznych w raku stercza. Wykorzystanie przezkroczowej biopsji fuzyjnej, jako narzędzia pozwalającego na uzyskanie materiału diagnostycznego
adres e-mail: konferencjanowotworydziedziczne@wp.pl.


